Figure 2.
Kaplan-Meier analysis of overall survival in patients treated with sorafenib (solid line; n=20) and those treated with NFP (dotted line; n=44). The median survival times were 13.2 and 30.4 months, respectively (P=0.013).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.